title: Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma.
authors: INSERM U 113, Paris, France.
authors: J M
authors: JM
authors: Guliana
authors: P J
authors: PJ
authors: Guillausseau
authors: J
authors: J
authors: Caron
authors: C
authors: C
authors: Siame-Mourot
authors: C
authors: C
authors: Calmettes
authors: E
authors: E
authors: Modigliani
mesh_terms: D000293:Adolescent; D000328:Adult; D002116:Calcitonin / Q000097:blood*; D002277:Carcinoma / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000097:blood / Q000188:drug therapy*
chemical_list: D002116:Calcitonin; D015282:Octreotide